View the CAT printer-friendly / share this CAT
Title Continuous Positive Airway Pressure (CPAP) May Immediately Decrease Persistent Hypertension in Patients with Obstructive Sleep Apnea (OSA)
Clinical Question In patients with obstructive sleep apnea with uncontrolled hypertension that is not alleviated by medication, can the use of continuous positive airway pressure (CPAP) lower both diastolic and systolic blood pressure?
Clinical Bottom Line In patients with obstructive sleep apnea and systemic hypertension that is not controlled by medication, the use of CPAP device can aid in decreasing blood pressure if obstructive sleep apnea is controlled. This is supported by two meta-analyses and a randomized controlled trial that showed clinically a decrease in both systolic and diastolic blood pressure in a standard 24-hour period. Further research is needed for longer-term health outcomes.
Best Evidence (you may view more info by clicking on the PubMed ID link)
PubMed ID Author / Year Patient Group Study type
(level of evidence)
#1) 24733980Bakker/2014968 adults with OSA without major comorbidities drawn from 8 randomized controlled trialsMeta-Analysis
Key resultsPatients with OSA and uncontrolled hypertension are likely to have substantial reduction in blood pressure with the use of the CPAP machine. Systolic BP (SBP) was reduced by 7.1 mmHg and diastolic BP (DBP) by 4.3 mmHg after controlling for OSA severity. In comparison, patients without baseline hypertension did not have a significant decrease in blood pressure. This information was collected during a single standard 24-hour period or single day office visit, hence limiting reproducibility. Patients with uncontrolled hypertension and OSA would have the greatest benefit from using a CPAP.
#2) 24841834Verounis/20145 studies with a total of 359 patients with uncontrolled HTN. CPAP treatment measured after 24 hours.Meta-Analysis
Key resultsThis study calculated the mean difference (MD) between ambulatory blood pressure monitoring (ABPM) recordings taken during 24-hr follow-up. The average duration that the CPAP was used in these patients ranged from 4.2 to 6 hours per night. In RCTs that used only the CPAP arm and in uncontrolled observational studies, there was a significant reduction in both 24-hr systolic and diastolic BP compared to pre-CPAP levels ([MD = −4.6 mm Hg (95% CI= −6.3 to −2.9, p < 0.001)], [MD = −2.9 mm Hg (95% CI = −4.4 to −1.3, p < 0.001)] respectively). CPAP had a favorable effect after 24-hr BP was recorded during follow-up compared to standard anti-HTN treatment with patients having both OSA and uncontrolled HTN.
#3) 24327037Martinez-Garcia/2014174 patients in a randomized, clinical trial of parallel groups with blinded end point design conducted on patients with OSA and HTN.Randomized Controlled Trial
Key resultsThis RCT had 194 patients randomized to CPAP (n=98) or no CPAP (n=96), but only 174 (87 CPAP, 87 control) completed the study with valid 24-hr ABPM measurements. The CPAP machine was used at least 4 hours per night with a mean pressure of 8.5 mmHg. In the pre-protocol analysis, patients in the CPAP group showed significant decrease in a 24-hour average BP reading (4.4 mm Hg (95% CI, 1.8 to 7 mmHg), P = .001; SBP, 4.9 mm Hg (95% CI, 1.2 to 8.6 mmHg), P = .01; and DBP, 4.1 mm Hg (95% CI, 1.9 to 6.4 mmHg), P < .001). There was a positive linear correlation between number of hours of CPAP use and the decrease in 24-hour mean BP (r = 0.29, P = .006); SBP, (r = 0.25; P = .02); and DBP, (r = 0.30, P = .005).
Evidence Search (("Sleep Apnea, Obstructive"[Mesh]) AND "Continuous Positive Airway Pressure"[Mesh]) AND "Hypertension"[Mesh]
Comments on
The Evidence
Bakker’s meta-analysis included 968 adult patients with OSA that had no major comorbidities drawn from 8 RCTs. They divided the groups between therapeutic PAP (486 patients) and non-therapeutic control conditions (482 patients) over a standard 24-hr period. This study stated no financial conflict of interest and took into account independent (predictors such as age, gender, BMI at baseline, therapeutic PAP levels, AHI severity, and treatment duration) and dependent (outcomes such as all blood pressure data available) variables. This study demonstrated a clinically significant reduction in BP for patients having uncontrolled hypertension at baseline only, but not for patients having controlled hypertension. The Verounis meta-analysis of RCTs and uncontrolled observational studies (n= 190 patients) showed significant reduction in blood pressure in patients with uncontrolled hypertension. In the Martinez study, patients were randomly assigned to receive CPAP or no CPAP treatment. These patients, on average, were taking 3.8 antihypertensive drugs and had a mean apnea-hypopnea index (AHI) of 40.4 (SD, 18.9). There was a significant positive correlation between hours of CPAP use and decrease in a 24 hour period of mean BP, but further research is needed to assess longer-term health outcomes. No conflict of interest was reported.
Applicability A continuous positive airway pressure device can reduce obstructive sleep apnea in patients with systemic hypertension that is not alleviated by medications within a 24-hour period. Both systolic and diastolic pressures have shown a clinically significant decrease within those 24 hours; however, more research is needed to determine longer-term outcomes.
Specialty/Discipline (General Dentistry)
Keywords Obstructive sleep apnea, hypertension, continuous positive airway pressure
ID# 2874
Date of submission: 04/04/2015spacer
E-mail lomeliv@livemail.uthscsa.edu
Author Valeria Lomeli
Co-author(s) e-mail
Faculty mentor/Co-author Kevin M. Gureckis, DMD
Faculty mentor/Co-author e-mail gureckis@uthscsa.edu
Basic Science Rationale
(Mechanisms that may account for and/or explain the clinical question, i.e. is the answer to the clinical question consistent with basic biological, physical and/or behavioral science principles, laws and research?)
post a rationale
None available
Comments and Evidence-Based Updates on the CAT
post a comment
None available

Return to Found CATs list